Heart-lung Machine Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global heart-lung machine market was valued at USD 369.8 million in 2024 and is expected to exhibit growth at a CAGR of 4.6% from 2025 to 2034 period. The market growth is attributed to the increasing prevalence of cardiovascular disease, growing number of organ transplant surgeries, contributing to their growing adoption.
The global burden of cardiovascular diseases has been steadily rising due to factors such as aging populations, sedentary lifestyles, poor dietary habits, and increasing rates of hypertension and diabetes. According to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths annually, representing 32% of all global deaths. These conditions often necessitate surgeries that require the use of heart-lung machines for effective cardiac support, driving the demand for these cardiovascular devices.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
Heart-lung Machine Market size in 2024: | USD 369.8 Million |
Forecast Period: | 2025 – 2034 |
Forecast Period 2023 - 2032 CAGR: | 4.6 |
2023 Value Projection: | USD 575.9 Million |
Historical Data for: | 2021 – 2024 |
No of Pages: | 130 |
Tables, Charts & Figures: | 119 |
Segments Covered: | Type, Application, End Use, Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
A heart-lung machine, also known as a cardiopulmonary bypass (CPB) machine, is a medical device used for open-heart surgeries to temporarily take over the functions of the heart and lungs. The heart-lung machine performs the essential tasks of oxygenating the blood, removing carbon dioxide, and circulating the oxygenated blood back into the patient's body.
Technological advancements in heart-lung machines are a key growth driver for the market, as innovations in design, functionality, and performance continue to enhance the capabilities of these critical devices. These advancements have improved the safety, efficiency, and ease of use of heart-lung machines, making them an essential tool in cardiovascular surgeries and other complex procedures.
Based on type, the market is segmented as single roller pump and double roller pump. The single roller pump segment is expected to drive business growth and expand at a CAGR of 4.3%, reaching over USD 337 million by 2034.
Based on application, the heart-lung machine market is classified into cardiac surgeries, lung surgeries, acute respiratory failure treatment, and other applications. The cardiac surgeries segment dominated the market with a revenue share of 40.4% in 2024.
Based on end use, the heart-lung machine market is classified into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment dominated the market in 2024 and is anticipated to reach USD 241.4 million by the end of the forecast period.
The U.S. heart-lung machine market accounted for USD 139.6 million in 2024 and is anticipated to grow at a CAGR of 3.9% between 2025 to 2034 period.
France heart-lung machine market is projected to grow remarkably in the coming years.
Japan holds a dominant position in the Asia Pacific heart-lung machine market.
Several key players in the market are making strides in type innovation and strategic partnerships to maintain market leadership. Companies are investing heavily in R&D to develop advanced heart-lung machines with enhanced features such as real-time monitoring, integration with other surgical equipment, and enhanced biocompatibility. Additionally, partnerships with healthcare providers are being forged to improve type accessibility in emerging markets. Regulatory compliance and adherence to international quality standards are crucial aspects of the strategies employed by these companies to cater to a global market. These developments are helping companies meet the increasing demand for safe and efficient heart-lung machines.
Prominent players operating in the heart-lung machine industry include:
The heart-lung machine market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Market, By Type
Market, By Application
Market, By End Use
The above information is provided for the following regions and countries:
The single roller pump segment is expected to grow at a CAGR of 4.3%, reaching over USD 337 million by 2034, due to its reliability in maintaining consistent blood flow during surgeries and its efficient mechanism for prolonged extracorporeal circulation.
Key players in the industry include BRAILE, Edwards, ELITE LIFE CARE, EUROSETS, FRESENIUS MEDICAL CARE, GETINGE, HEART CARE INDIA CO, hemovent, Jarvik HEART, LivaNova, Medtronic, NIPRO, Palex, Philips, and TERUMO.
The U.S. heart-lung machine market was valued at USD 139.6 million in 2024 and is anticipated to grow at a CAGR of 3.9% from 2025 to 2034, supported by the high volume of cardiac surgeries, including CABG and valve replacements.
The global heart-lung machine industry was valued at USD 369.8 million in 2024 and is projected to grow at a CAGR of 4.6% from 2025 to 2034, driven by the increasing prevalence of cardiovascular diseases and rising organ transplant surgeries.